eradication of many infectious diseases, developing of parasites vaccines such as malaria
vaccine is very complex. The most advanced malaria vaccine candidate RTS, S, a pre-
erythrocytic vaccine, has been recommended for licensure by EMEA. The results of this
phase III trial suggest that this candidate malaria vaccine has relatively little efficacy, and the
vaccine apparently will not meet the goal of malaria eradication by itself. Since there are …